Mark Velleca, StrideBio CEO
Ginkgo snaps up gene therapy vector assets from StrideBio
Ginkgo Bioworks is picking up some viral vectors, part of what it calls an ongoing push into gene therapy services.
On Wednesday, Ginkgo announced that …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
